Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin vs Vancomycin for C. difficile Spore Inhibition
NCT01818141Phase 4Completed
- Sponsor
- Hartford Hospital
- Start
- Oct 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by Hartford Hospital. Started Oct 2012; status: completed.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT01818141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818141.